WordNet

an inherited form of anemia caused by faulty synthesis of hemoglobin (同)thalassaemia, Mediterranean_anemia, Mediterranean anaemia

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 造血細胞移植後のサラセミア患者の長期マネージメント long term management of the thalassemic patient after hematopoietic cell transplantation
2. サラセミア症候群の分子病理 molecular pathology of the thalassemic syndromes
3. βサラセミアの病態生理 pathophysiology of beta thalassemia
4. 地域社会の公衆衛生上の問題とサラセミア症候群：他国から得た教訓 community public health issues and the thalassemic syndromes lessons from other countries
5. αサラセミアの病態生理 pathophysiology of alpha thalassemia

Iron chelation therapy as a treatment for Pythium insidiosum in an animal model.

Zanette RA, Alves SH, Pilotto MB, Weiblen C, Fighera RA, Wolkmer P, Flores MM, Santurio JM.SourcePrograma de Pós-graduação em Farmacologia, Universidade Federal de Santa Maria, Santa Maria, Brazil.
The Journal of antimicrobial chemotherapy.J Antimicrob Chemother.2013 Jan 17. [Epub ahead of print]
OBJECTIVES: Iron plays an important role in the pathogenesis of Pythium insidiosum. Human pythiosis frequently occurs in iron-overloaded thalassaemic patients and experimentally infected animals develop iron deficiency anaemia. Therefore, we sought to determine the in vitro and in vivo activities of
PMID 23329785

Walter PB, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, Coates T, Giardina PJ, Grady RW, Vichinsky E, Olivieri N, Trachtenberg F, Alberti D, Fung E, Ames B, Higa A, Harmatz P; Thalassemia Clinical Research Network.SourceChildren's Hospital & Research Center Oakland, Oakland, CA, USA; Department of Biology, University of Victoria, Victoria, Canada.
British journal of haematology.Br J Haematol.2012 Dec 6. doi: 10.1111/bjh.12076. [Epub ahead of print]
This exploratory study assessed apoptosis in peripheral blood leucocytes (PBL) from β-thalassaemia patients receiving chronic transfusions and chelation therapy (deferasirox or deferoxamine) at baseline, 1, 6, and 12 months. At baseline, thalassaemic PBLs presented 50% greater levels of Bax (BAX),
PMID 23216540

Evaluation and cost analysis of national health policy of thalassaemia screening in west-azerbaijan province of iran.

Ahmadnezhad E, Sepehrvand N, Jahani FF, Hatami S, Kargar C, Mirmohammadkhani M, Bazargan-Hejazi S.SourceDepartment of Epidemiology & Biostatistics, Tehran University of Medical Sciences, Iran.
International journal of preventive medicine.Int J Prev Med.2012 Oct;3(10):687-92.
BACKGROUND: Thalassaemia is one of the most common Mendelian disorders in Mediterranean area. Iran has about 26,000 Thalassaemic patients, so it is one of the most affected countries. The aim of this study was to evaluate the screening program and cost analysis of Thalassaemia prevention program in
PMID 23112894